['diabetic macular edema']
['regn910-3', 'intravitreal aflibercept injection (iai)']

        Key Inclusion Criteria:

          1. Men or women ≥18 years of age with type 1 or type 2 diabetes mellitus who have
             clinically significant DME with central involvement in the study eye

          2. BCVA ETDRS letter score of 73 to 24 (Snellen equivalent of 20/40 to 20/320) in the
             study eye

          3. Willing and able to comply with clinic visits and study-related procedures

          4. Provide signed informed consent

        Key Exclusion Criteria:

          1. Evidence of macular edema due to any cause other than diabetes mellitus in either eye

          2. IVT anti-VEGF in the study eye within 12 weeks of the screening visit

          3. Panretinal laser photocoagulation or macular laser photocoagulation in the study eye
             within 3 months of screening

        Note: Other inclusion/ exclusion criteria apply
      